ELV
Elevance Health Inc
Elevance Health Inc historical holders
total: 18
Bill & Melinda Gates Foundation Trust Elevance Health Inc transactions over time
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2023 Q3
- Held for:
- 1 quarter
- Latest activity:
- 2023 Q4
Bill Gates has been an institutional investor in Elevance Health Inc (ELV) since 2023 Q3. According to 2026 Q2 report, Bill Gates doesn't hold any shares. The fund/company first acquired ELV in 2023 Q3, initially purchasing 8,500 shares. Since the initial investment, Bill & Melinda Gates Foundation Trust has made 1 more transaction in this position.
When did Bill Gates exit their ELV position?
Bill Gates no longer holds Elevance Health Inc (ELV). They sold off their entire position in 2023 Q4, closing out an investment that began in 2023 Q3.
When did Bill Gates first invest in ELV?
Bill Gates first invested in Elevance Health Inc (ELV) in 2023 Q3 at the reported quarter-end price of $435.42 per share, acquiring 8,500 shares in their initial purchase.
What is Bill Gates's average cost basis for ELV?
Based on historical transaction data, Bill Gates's estimated cost basis for Elevance Health Inc (ELV) is approximately $435.42 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $435.42
- Weighted AVG sell price:
- $435.42
ELV transactions history by Bill & Melinda Gates Foundation Trust
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2023 Q4
|
0.00%
|
0
|
$435.42
|
|
-100% (-8,500)
|
-0.01%
|
|
2023 Q3
|
0.01%
|
8,500
|
$435.42
|
$3,701,070
|
new
|
+0.01%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.